Back to Search
Start Over
[Anabolic therapy in patients with HIV infections].
- Source :
-
Terapevticheskii arkhiv [Ter Arkh] 1999; Vol. 71 (11), pp. 35-7. - Publication Year :
- 1999
-
Abstract
- Aim: To assess effectiveness of Deka-Duraboline--preparation of anabolic steroid hormone (nandrolone decanoate)--in the treatment of weight loss in AIDS patients.<br />Materials and Methods: 13 AIDS patients with weight loss < 10% admitted to Moscow Center of AIDS Prevention and Treatment were given Deka-Durabolin 1 time a week 50 mg intramuscularly for 12 weeks after failure of attempts to arrest weight loss. Body mass, diarrhea, appetite and general condition (visual analogue scale) were studied.<br />Results: Deka-Duraboline treatment arrested weight loss in 12 of 13 cases, improved well-being. All the patients displayed better appetite, reduced diarrhea.<br />Conclusion: Deka-Duraboline is effective in improving body weight, appetite, diarrhea and well-being in AIDS patients. It is advisable to further study Deka-Duraboline in a controlled randomized trial.
- Subjects :
- Adult
Anabolic Agents administration & dosage
Appetite drug effects
Body Mass Index
Diarrhea etiology
Diarrhea prevention & control
Female
HIV Infections complications
Humans
Injections, Intramuscular
Male
Nandrolone administration & dosage
Nandrolone therapeutic use
Quality of Life
Treatment Outcome
Weight Loss drug effects
Anabolic Agents therapeutic use
HIV
HIV Infections drug therapy
Nandrolone analogs & derivatives
Subjects
Details
- Language :
- Russian
- ISSN :
- 0040-3660
- Volume :
- 71
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- Terapevticheskii arkhiv
- Publication Type :
- Academic Journal
- Accession number :
- 10626332